標(biāo)題: Titlebook: Recent Trends in Cancer Biology: Spotlight on Signaling Cascades and microRNAs; Cell Signaling Pathw Sundas Fayyaz,Ammad Ahmad Farooqi Book [打印本頁] 作者: 使沮喪 時(shí)間: 2025-3-21 19:01
書目名稱Recent Trends in Cancer Biology: Spotlight on Signaling Cascades and microRNAs影響因子(影響力)
書目名稱Recent Trends in Cancer Biology: Spotlight on Signaling Cascades and microRNAs影響因子(影響力)學(xué)科排名
書目名稱Recent Trends in Cancer Biology: Spotlight on Signaling Cascades and microRNAs網(wǎng)絡(luò)公開度
書目名稱Recent Trends in Cancer Biology: Spotlight on Signaling Cascades and microRNAs網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Recent Trends in Cancer Biology: Spotlight on Signaling Cascades and microRNAs被引頻次
書目名稱Recent Trends in Cancer Biology: Spotlight on Signaling Cascades and microRNAs被引頻次學(xué)科排名
書目名稱Recent Trends in Cancer Biology: Spotlight on Signaling Cascades and microRNAs年度引用
書目名稱Recent Trends in Cancer Biology: Spotlight on Signaling Cascades and microRNAs年度引用學(xué)科排名
書目名稱Recent Trends in Cancer Biology: Spotlight on Signaling Cascades and microRNAs讀者反饋
書目名稱Recent Trends in Cancer Biology: Spotlight on Signaling Cascades and microRNAs讀者反饋學(xué)科排名
作者: 反復(fù)拉緊 時(shí)間: 2025-3-21 23:40 作者: 包租車船 時(shí)間: 2025-3-22 01:22
When the Molecules Start Playing Chess, or How MicroRNAs Acquire Dualistic Activity During Cancer Ppressor microRNAs into tumor promoting omcomiRs. Understanding mechanics of this dualism will reveal how far tumor progression could go. This chapter will discuss some aspects of the current knowledge and understanding of this side of oncogenesis.作者: 議程 時(shí)間: 2025-3-22 07:56
From Endometriosis to Cancer: Spotlight on Intracellular Signaling Cascades and MicroRNAs,ways promote transformations from benign to premalignant endometriosis. It is becoming progressively more understandable that genetic/epigenetic mutations, inactivation of tumor suppressors, aberrant expression of different microRNAs play decisive role in malignant transformation of endometriosis.作者: 具體 時(shí)間: 2025-3-22 11:39
Tyrosine Kinases, microRNAs, Epigenetics: New Insights in the Mechanisms of Leukemogenesis,tudies have contributed to deepen the knowledge of the mechanisms underlying leukemogenesis. Interestingly, different types of leukemias may share the same molecular abnormality (for example, the loss of the . gene). Conversely, only few haematological malignancies harbour a single and specific aber作者: LAPSE 時(shí)間: 2025-3-22 15:03 作者: BRAWL 時(shí)間: 2025-3-22 17:51
Tranquilizing and Awakening ATM to Promote Killing of Cancer Cells, sources. To overcome these stumbling blocks, cells have evolved a global DNA damage response (DDR), which is an intricate and hierarchically organized network of interweaved pathways that are “switched on” whenever genotoxic insults occurs. ATM, ATR, and DNA-PK are multitalented modulators of DNA d作者: 激勵 時(shí)間: 2025-3-22 21:57 作者: 諷刺 時(shí)間: 2025-3-23 05:20
Bone Cancer: Dysregulation of Signaling Cascades by microRNAs,nd osteocyte cells. Complex regulatory networks are required during these events in osteogenesis, and their imbalance can cause disastrous disordering and consequently diseases, such as cancer. Bone-related diseases involve a deregulation of genes, microRNAs, transcription factors (TF) or proteins i作者: 枕墊 時(shí)間: 2025-3-23 09:13
The Roles of miR-25 and Its Targeted Genes in Human Cancer,s. miRNAs are small non-coding RNAs that regulate gene expression by targeting messenger RNAs for translational repression or, at lesser extent, mRNAs degradation. Within the several functions controlled by miRNAs there are the control of cell proliferation, apoptosis, differentiation, cell migratio作者: 四牛在彎曲 時(shí)間: 2025-3-23 13:06 作者: ALIEN 時(shí)間: 2025-3-23 17:37
,TGF-β/Smad Signalling Pathway in Cancer,tional in development of cancer. In early stages of tumour development, TGF-β plays tumour suppressive, and as tumour progressed, TGF-β is an oncogenic factor. Functioning as tumour suppressor, TGF-β is a potential growth inhibitor. Cancerous cells show high sensitivity to TGF-β inhibition either by作者: Moderate 時(shí)間: 2025-3-23 20:46 作者: 代替 時(shí)間: 2025-3-24 01:29
Sebaceous Carcinoma of the Eyelid,25%. Historical studies have shown that mortality rates could be as high as 83%, but with the advent of increased detection, diagnosis, and treatment options, mortality rates have dropped substantially. A major issue with obtaining a proper diagnosis of SC is that it can mimic many other benign and 作者: 吃掉 時(shí)間: 2025-3-24 04:03 作者: 放逐 時(shí)間: 2025-3-24 07:04 作者: 遠(yuǎn)足 時(shí)間: 2025-3-24 11:15 作者: ostensible 時(shí)間: 2025-3-24 16:14
The Crosstalk Between miRNAs and Autophagy in Cancer Progression,ion of miRNAs is linked to many human diseases including cancer. Impaired levels of miRNAs may also result in defected autophagy. Autophagy is a double-edged sword during cancer initiation and progression. At the beginning of tumorigenesis, autophagy suppresses tumor formation by removing defective 作者: 斗志 時(shí)間: 2025-3-24 21:37
Role of CEACAM in Different Cancers,pment and progression. The greatest stumbling block in improving the clinical outcome of cancer patients is that tumors continuously adapt to their micro-environment and evolve ways to develop resistance against molecular therapeutics. We are developing systems-level understanding of tumors about th作者: 確定的事 時(shí)間: 2025-3-24 23:12 作者: 無能性 時(shí)間: 2025-3-25 06:11 作者: 遺產(chǎn) 時(shí)間: 2025-3-25 10:23 作者: 拱形面包 時(shí)間: 2025-3-25 13:52
The Crosstalk Between miRNAs and Autophagy in Cancer Progression,agy is a survival pathway for tumor cells under the low levels of oxygen (hypoxia), deprivation of growth factors and glucose. The main focus of this chapter is the interplay between miRNAs and autophagy during initiation and progression of cancer.作者: Collected 時(shí)間: 2025-3-25 16:18
Book 2018tastasis and resistance against wide ranging therapeutics..This book offers a balanced overview of the rapidly emerging cutting edge research in molecular oncology and good source of knowledge for established oncologists, basic and medical students and pharmaceutical industry associated R&D departments..作者: 決定性 時(shí)間: 2025-3-25 23:12 作者: photophobia 時(shí)間: 2025-3-26 00:54 作者: 節(jié)省 時(shí)間: 2025-3-26 06:57 作者: BURSA 時(shí)間: 2025-3-26 11:33 作者: jovial 時(shí)間: 2025-3-26 14:20 作者: indenture 時(shí)間: 2025-3-26 19:34
Yi Chieh Lim,Shahzad Bhatti,Ammad Ahmad Farooqie are unable to find a metrology for prescriptive decision paradigms. As a result, we developed a metrology and measurement instrument. To our knowledge . We invite scholars to research this subject and add to the body of knowledge of metrology in the praxis of decision theory.作者: 發(fā)源 時(shí)間: 2025-3-26 23:39
Marília I. Figueira,Henrique J. Cardoso,Sílvia Socorrotype of fa?ade, the book provides explanations and scientific information for investigating and designing the advanced fa?ades according to the characteristics of the mullions and transoms fa?ade system (stick system), of the structural sealant glazing fa?ade system, of the unit fa?ade system, of th作者: 清洗 時(shí)間: 2025-3-27 04:03 作者: blister 時(shí)間: 2025-3-27 05:27 作者: 膽汁 時(shí)間: 2025-3-27 11:54 作者: Agility 時(shí)間: 2025-3-27 15:14 作者: 蚊子 時(shí)間: 2025-3-27 20:29
Carmen Caiazza,Palmiro Poltronieri,Massimo Mallardo作者: Parameter 時(shí)間: 2025-3-28 00:26 作者: BINGE 時(shí)間: 2025-3-28 04:25 作者: CALL 時(shí)間: 2025-3-28 08:13
Recent Trends in Cancer Biology: Spotlight on Signaling Cascades and microRNAs978-3-319-71553-7作者: 面包屑 時(shí)間: 2025-3-28 13:14
Mohadeseh Hasanpourghadi,Mohd. Rais Mustafagress in the journey. ..In this book Santiago I?iguez de Onzo?o, President of IE University, and Peter Lorange, former President of IMD, bring together contributions from leading figures from some of the world’978-3-030-82345-0978-3-030-82343-6作者: 驚惶 時(shí)間: 2025-3-28 15:11 作者: 心神不寧 時(shí)間: 2025-3-28 22:17 作者: ARY 時(shí)間: 2025-3-29 01:59
The Role of GPER Signaling in Carcinogenesis: A Focus on Prostate Cancer,th several pathological conditions such as cardiovascular diseases, obesity, diabetes, Parkinson, stroke, and cancer. GPER has been linked with the carcinogenic process, though some ambiguity exists concerning its protective or causative role in different tissues, or even in the same tissue. This ch作者: 招人嫉妒 時(shí)間: 2025-3-29 05:23
Bone Cancer: Dysregulation of Signaling Cascades by microRNAs,at heterogeneous and complex diseases. These new meta-analysis methods—omics technologies—will be useful for more efficient analyses of a vast number of data generated by the multidisciplinary areas involved in the translational studies for medicine. The information about miRNAs associations with bo作者: 無畏 時(shí)間: 2025-3-29 09:16
The Roles of miR-25 and Its Targeted Genes in Human Cancer,target. Here, we want to briefly discuss the mechanisms underlying miRNA-mediated tumorigenesis in different human cancers, presenting, as an example, the oncogenic and tumor-suppressive function of miR-25. Moreover, we summarize the possible future as a potential diagnostic and prognostic parameter作者: Fissure 時(shí)間: 2025-3-29 14:16 作者: archaeology 時(shí)間: 2025-3-29 17:42
Sebaceous Carcinoma of the Eyelid,ial seeding of the tumor cells, metastasis, or orbital invasion, other methods such as chemotherapy, radiation, and exenteration must be performed. It is essential that we elucidate the cellular mechanisms regarding the etiology of SC to develop better methods of diagnosis and treatment for the futu作者: Frenetic 時(shí)間: 2025-3-29 19:49
Current Knowledge of miRNAs as Biomarkers in Breast Cancer, operating in a post-transcriptional level by regulating gene expression. Aberrant miRNA expression was documented in several pathological conditions, including solid tumors, suggesting their involvement in tumorigenesis. MiRNAs can be detected in human fluids and could be used as biomarkers. A diff作者: FLIC 時(shí)間: 2025-3-30 01:00
Signaling Landscape of AML: The Story So Far,the signaling proteins identified as specifically mutated in AML have raised huge consideration as attractive therapeutic targets and many efforts are currently ongoing in order to design . strategies to improve prognosis and therapy. Recent advances in the conventional treatments, together with inn作者: 燈絲 時(shí)間: 2025-3-30 06:42 作者: 小丑 時(shí)間: 2025-3-30 11:07
978-3-030-10074-2Springer International Publishing AG, part of Springer Nature 2018作者: Hyperalgesia 時(shí)間: 2025-3-30 15:14
http://image.papertrans.cn/r/image/823403.jpg作者: 有權(quán)威 時(shí)間: 2025-3-30 19:10
https://doi.org/10.1007/978-3-319-71553-7Signaling Cascades; Molecular Oncology; Cancer Development and Progression; Signal Transduction; microRN作者: 反感 時(shí)間: 2025-3-30 20:52 作者: 迅速成長 時(shí)間: 2025-3-31 04:36
Natural Agents Mediated Regulation of microRNAs: Do We Need Skilled Archers to Hit the Bullseye,o reportedly involved in regulation of carcinogenesis, angiogenesis, apoptosis, cell proliferation and aging. Recent studies have shown that natural agents exert their anti-cancer effects via regulation of miRNAs. In this work, we summarize the regulation of miRNAs by natural agents as new strategy in cancer treatment.作者: BABY 時(shí)間: 2025-3-31 08:01 作者: Favorable 時(shí)間: 2025-3-31 12:20
Talha Abdul Halim,Rukset Attar,Cristina Donfrancesco,Ammad Ahmad Farooqi,Farrukh Zamanght bulb, a used car, or a radio. To answer “does it work” in a meaningful and thoughtful way, we adopt the approach used by pharmaceutical companies. Demonstrating that a drug works is a stringent process, which is also regulated by unforgiving laws. A drug works if its developers can verify that i作者: 黑豹 時(shí)間: 2025-3-31 13:23
Maria Ciccone,George A. Calinght bulb, a used car, or a radio. To answer “does it work” in a meaningful and thoughtful way, we adopt the approach used by pharmaceutical companies. Demonstrating that a drug works is a stringent process, which is also regulated by unforgiving laws. A drug works if its developers can verify that i作者: invulnerable 時(shí)間: 2025-3-31 19:57
Carolina F. Ruivo,Sónia A. Meloght bulb, a used car, or a radio. To answer “does it work” in a meaningful and thoughtful way, we adopt the approach used by pharmaceutical companies. Demonstrating that a drug works is a stringent process, which is also regulated by unforgiving laws. A drug works if its developers can verify that i
